Just-in-time gets the boot as resilience costs rise

The gist

Just-in-time is out—the world’s biggest companies are paying up for resilience after global supply chains buckled in 2026.

What to know

  • By July-November 2026, container reliability slumped to 62.6% with late ships 5.3 days behind, forcing firms to ditch lean inventories for buffer stocks and domestic capacity.
  • GE Aerospace cut critical-component lead times by 60%, GM is spending up to $1.5 billion to reshore production, and Lululemon’s new Brampton hub uses 525 robots to keep goods flowing.
  • The resilience race is fiercest in pharma and minerals, with BD’s $19B U.S. medical expansion and Japan investing 110M euros in rare-earths to avoid life-threatening shortages.

JIT’s Weakest Link Exposed

Supply chains built on just-in-time crumbled as late shipments and semiconductor shortages turned single delays into multi-million dollar shutdowns.

By late summer 2026, the public case against pure just-in-time had shifted from theory to evidence: “In June, global container schedule reliability was just 62.6%,” with late vessels arriving “an average of 5.3 days behind schedule,” a direct hit to a model that only works when cargo shows up on cue. Against that backdrop, companies were openly rethinking inventory and sourcing, and Breakbulk.News captured the turn in July: firms were talking less about just in time and more about just in case, with nearshoring and reshoring elevated to boardroom priorities.

The shift was also becoming sector-specific and operational by September, especially in electronics, where Supply Chain Brain wrote that “for three decades, the gospel of just-in-time (JIT) inventory management went virtually unchallenged” but that pure JIT had become “a single point of failure.” That was not rhetorical overreach: “When a single $2 power management IC or specialized memory controller fails to arrive on time, a $5,000 server assembly line halts,” a vulnerability worsened by “volatile semiconductor node transitions,” “specialized memory module lead times stretching past 30 weeks,” and “persistent geopolitical friction along primary shipping lanes.”

Sources

Inventory Becomes Strategic Armor

Companies are stockpiling and reshoring, not for efficiency, but to outmaneuver geopolitical shocks and chronic supply delays.

The shift is visible not in rhetoric but in operating choices: companies are carrying more protection into the system through inventory, supplier coverage, and faster recovery capability, a response to geopolitical and trade disruptions that have accumulated since 2020. Supply Chain Now captured the logic bluntly — “just in time… it ain't going to cut it anymore” — while GE Aerospace, reported by Supply Chain Dive, focused on “reducing production lead time for critical components by whopping 60%,” a move tied to F110 engine deliveries rising 50% year over year in Q2 2026 and showing resilience being built into production itself.

That same resilience playbook extends beyond factories into network design and domestic capacity: “for decades, supply chains were optimized for efficiency,” but “those assumptions no longer hold” because of “geopolitical tensions” and transport disruptions, including Europe’s 2026 low-water shipping problems, with the article linking the move toward robustness to geopolitical and trade disruptions that have accumulated since 2020. GM is “planning to spend an additional 1 to 1.5 billion… to own share more production to the US in 2027,” while also expanding its Micron relationship to protect access to memory chips, and the broader buildout logic is echoed by the long ramp of TSMC in Arizona: “We started building that factory almost four or five years ago or six years ago.”

Sources

Redundancy Redefines Supply Networks

Risk-based planning and multi-node networks are replacing minimum-inventory models as firms scramble to avoid single points of failure.

Resilience is being built into day-to-day operating design by carrying more critical stock, spreading supply across more than one source, and deciding inventory by risk rather than by minimum levels alone. FleetOwner reported fleets shifting from just-in-time parts management toward risk-based strategies to protect uptime, while Air Cargo Week described companies adding dual sourcing, multiple routes and regional stockholding so that “a single failure does not bring the network to a halt”; at Solventum, chief commercial officer Heather Knight said “Constant scenario planning is needed,” spanning “weather events, cybersecurity issues, geopolitical tensions or a supplier suddenly” discontinuing a component.

The same logic is now visible in physical capacity: companies are building or controlling more manufacturing, warehousing and transport nodes so disruption in one place does not stop delivery everywhere. Vantive’s Christopher Toth said the company has “20 global manufacturing facilities,” warning that if “suddenly those products could not get to a home, it would be catastrophic”; after a fire destroyed Medline’s 1 million-square-foot Tracy, Calif., distribution center, it shifted orders to secondary and tertiary sites, while BayCare’s 250,000-square-foot service center maintained a 99.3% fill rate, BJC’s 416,000-square-foot hub lifted fulfillment above 99%, and Becker’s Hospital Review reported: “Hartford HealthCare invests $17.4M in centralized medication distribution center.”

Sources

Resilience Now Costs Real Money

Building buffer capacity and redundancy is inflating balance sheets, forcing leaders to weigh resilience premiums against decades of cost-cutting orthodoxy.

The price of resilience starts with undoing decades of financial discipline built around stripping out slack. As Capital Mischief put it, “For forty years, managers were rewarded for removing redundancy,” because “Inventory tied up capital” and “Spare factories lowered utilization,” while “Excess generating capacity sat around doing nothing”; the same logic explains why resilience now looks like a deliberate premium, whether that means oil sitting in storage instead of earning money or a mine that “would never clear a private return hurdle without government support.”

That premium shows up directly on balance sheets and in capital budgets: Aviation Week reported aircraft component repair lead times stretching from “30-40 days to as much as 60-70 days since the COVID-19 crisis,” forcing operators to “hold more stock despite maintaining fleets of the same size,” while Retail Insider pointed to Lululemon’s Brampton distribution centre, which “exceeds one million square feet,” includes “525 AutoStore robots,” “292,000 storage bins” and “approximately eight kilometres of conveyors,” and “reflects a multiyear capital decision rather than a response to one quarter’s demand.”

Companies and health systems are therefore treating resilience as something to ration and justify, not simply adopt everywhere. Retail Insider said “Tariffs and supplier failures can accelerate production decisions,” citing Gather Packaging compressing “roughly two and a half to three months of work into approximately three weeks,” while Bill Moyer of Henry Ford Health called a consolidated service center “a very costly easy button” costing “$50 million to $100 million,” and UCLA Health’s Michael Baca described keeping “a 30-day supply in its warehouse and another 30 days with its distributor” so inventory “does not pile up.”

Sources

Life-Saving Supplies Drive Change

Pharma, healthcare, and minerals are leading the resilience charge, with governments and industry investing billions to secure critical, life-dependent inputs.

The shift is most visible where a missing input can immediately threaten lives or stop essential operations. In pharmaceuticals and adjacent mission-critical industries, the lesson was blunt: “with the lockdown, the first thing that got cut off in supply was medicines” and “Literally, life saving drugs were not available,” making diversification urgent because “You just can’t afford to depend on a single country for something this critical”; the same logic now extends to semiconductors, EV batteries and defense chemicals, while India’s pitch is “front shoring” through geography, saying “within 30 to 35 days we can reach Europe, Japan, and the US.”

Healthcare and critical minerals show the clearest institutional follow-through because shortages there can cripple care delivery or advanced manufacturing. Becker’s Hospital Review reported BD “struck a $19 billion agreement with the federal government to expand U.S. production,” planning to “add about 5 billion medical consumables a year” and “make all needles it sells in the U.S. domestically,” while hospital buyers are also using scale for resilience: Vizient, HealthTrust and Premier “served 84.1% of U.S. hospitals in 2024, up from 61.7% in 2014,” and supply chain leaders want contracts that give “resilience as much weight as cost”; in minerals, Japan backed this logic by committing up to 110 million euros to a French rare-earth refining and recycling project and securing half its output for Japan.

Sources

Get the stories behind the trends

Deep-dive reporting and the weekly brief, in your inbox.